Wege James, Anabtawi Mohammed, Blackwell Mike A, Patterson Alan
Oral and Maxillofacial Surgery, Castle Hill Hospital, Hull, GBR.
Oral and Maxillofacial Surgery, Chesterfield Royal Hospital, Chesterfield, GBR.
Cureus. 2021 Jan 27;13(1):e12929. doi: 10.7759/cureus.12929.
Administration of hyaluronic acid (HA) filler for aesthetic lip augmentation is a routine and common procedure with a low rate of adverse reactions. This case report documents an extremely rare complication of lip augmentation with HA leading to the development of lymphangiomas. Lymphangiomas are uncommon hamartomas of the lymphatic system. Although usually congenital, they can be acquired due to trauma, inflammation, or lymphatic blockage. They may be in the deep or superficial tissues, with superficial forms being either lymphangioma circumscriptum or acquired lymphangioma, also referred to as lymphangiectasia. Acquired lymphangiomas are typically formed by blockage of lymphatic drainage leading to dilation of the lymphatic channels. The diagnosis in our case report is acquired lymphangioma. A 27-year-old female presented with a two-year history of linear swellings in her upper lip. These lumps followed the line where HA filler had been injected four years earlier. Hyaluronidase had previously been used unsuccessfully to remove these lumps. The patient was treated with surgery to excise the lesions. Five masses were excised, and histopathological analysis displayed the presence of variably ectatic lacunae, lined by cells with CD34 expression, a lymph-vascular-endothelial marker. There were also scattered macrophages with CD68 expression in the interstices. These are typical features of a lymphangioma. The patient was satisfied with the excellent aesthetic and functional outcome. To our knowledge this is the first case of a lymphangioma following HA lip augmentation. Although rare, this complication can have aesthetic implications for the patient which may require further treatment or surgery to correct.
注射透明质酸(HA)填充剂进行唇部美容增大是一种常规且常见的手术,不良反应发生率较低。本病例报告记录了HA唇部增大极其罕见的并发症,导致淋巴管瘤的发生。淋巴管瘤是淋巴系统罕见的错构瘤。虽然通常是先天性的,但也可因创伤、炎症或淋巴阻塞而获得。它们可能位于深部或浅部组织,浅部形式为局限性淋巴管瘤或获得性淋巴管瘤,也称为淋巴管扩张症。获得性淋巴管瘤通常是由淋巴引流受阻导致淋巴管扩张形成的。我们病例报告中的诊断为获得性淋巴管瘤。一名27岁女性,上唇出现线状肿胀已有两年。这些肿块沿着四年前注射HA填充剂的线路分布。此前曾使用透明质酸酶试图消除这些肿块,但未成功。患者接受了手术切除病变。切除了五个肿块,组织病理学分析显示存在不同程度扩张的腔隙,内衬表达CD34的细胞,CD34是一种淋巴管内皮标志物。间隙中还散在有表达CD68的巨噬细胞。这些是淋巴管瘤的典型特征。患者对良好的美学和功能效果感到满意。据我们所知,这是HA唇部增大后发生淋巴管瘤的首例病例。尽管罕见,但这种并发症可能对患者的美观产生影响,可能需要进一步治疗或手术来纠正。